Functional significance of a C–>A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

Cited by (749)

Items 601–700 of 749

1. Research on the content and activity of CYP450 enzymes in human liver
   Cunzhen Zhang, Yan Fang, Lin-Jing Jia, Hai–Ling Qiao · 2025 · Drug Metabolism Reviews
2. Effects of Caffeine Dose and Administration Method on Time-Trial Performance: A Systematic Review and Network Meta-Analysis
   Ruiguo Xue, Jin Huang, Bin Chen, Li Ding, Li Guo, Yinhang Cao, Olivier Girard · 2025 · Nutrients
3. Genetic Variation in Melatonin Pathway Enzymes in Children with Autism Spectrum Disorder and Comorbid Sleep Onset Delay Olivia J. VeatchJulie S. PendergastMelissa J. AllenRoberta M. Leu • Carl Hirschie JohnsonSarah H. ElseaBeth A. Malow
   Olivia J. Veatch, Beth Ann Malow, Julie S. Pendergast, Michael J. Allen, Roberta M. Leu, Carl Hirschie Johnson, Sarah H. Elsea · 2015
4. Role of Caffeine in Sports Nutrition
   Lucas Guimarães‐Ferreira, Eric T. Trexler, Daniel A. Jaffe, Jason M. Cholewa · 2017 · Elsevier eBooks
5. [Retracted] Correlation Analysis of Cytochrome P450 SNPs in Hepatitis B‐Caused Cirrhosis Patients
   Qing‐Ya Li, Xiao-Na Yang, Zhi-Zhong Guo · 2022 · BioMed Research International · Retracted
6. Caffeine intervention after abstinence does not alter cognitive parameters in premenstrual syndrome women regardless of CYP1A2 genotype
   Renata Lira de Assis, Caroline Severo de Assis, Tainá Gomes Diniz, Bruno Rafael Virgínio de Sousa, Carla Alexandra da Silva Moita Minervino, Matheus Lima de Paiva, Vinícius José Baccin Martins, Enéas Ricardo de Morais Gomes, Marcelo Felipe Rodrigues da Silva, Yuri Mangueira do Nascimento et al. · 2024 · Journal of Functional Foods
7. Human genetics and caffeine: Functional single-nucleotide polymorphism and response to caffeine intake
   Agata Chmurzyńska · 2024 · Coffee in Health and Disease Prevention
8. A 6-year retrospective study of olanzapine plasma concentration inpatients with schizophrenia CYP1A2 polymorphisms in real-life settings
   Yan Zhang, Lisha Sun, Yanli Su, Hui Wang · 2024 · Heliyon
9. The Pharmacogenomics of Cytochrome P450s: From Molecular to Clinical Application
   Su‐Jun Lee, Jae‐Gook Shin · 2014 · Springer eBooks
10. Chapter 12 Cytochrome p450 (cyp) and udp-glucuronosyltransferase (ugt) enzymes: role in drug metabolism, polymorphism, and identification of their involvement in drug metabolism
    Anima Ghosal, Ragulan Ramanathan, Narendra S. Kishnani, Swapan K. Chowdhury, Kevin B. Alton · 2005 · Progress in pharmaceutical and biomedical analysis
11. Assessment of the relationship between combinations of polymorphic variants of xenobiotic-metabolizing enzyme genes and predisposition to lung cancer
    A. P. Mikhalenko, Крупнова Эвелина Вячеславовна, Natalya N. Chakova, N. V. Chebotareva, Yu. E. Demidchik · 2014 · Cytology and Genetics
12. New bearings in pharmacotherapeutic strategies: Pharmacogenetics and gene therapy
    Leposava Grbović, Miroslav Radenković, Jelena Djokić, Ljiljana Gojković‐Bukarica, Gordana Dragović · 2007 · Vojnosanitetski pregled
13. Association Study Between Functional Polymorphisms in the Cytochrome P450 1A2 and 2D6 Genes and Polydipsia in Schizophrenia
    Chima Matsumoto, Takahiro Shinkai, Vincenzo De Luca, Hiroko Hori, Rudi Hwang, Osamu Ohmori, James L. Kennedy, Jun Nakamura · 2006 · NeuroMolecular Medicine
14. Gene (CYP1A2, CYP2F1, NQO1, UGT2B7, CAT, GSTP1)—Environmental interactions analysis in occupational
    Leysan Zinurovna Akhmadishina, Gulnaz Faritovna Korytina, О. В. Кочетова, Tatiana V. Viktorova · 2015 · Russian Journal of Genetics Applied Research
15. Coffee Health Effects from Early Fetal Development Through Childhood and Adolescence
    Roseane Maria Maia Santos, Darcy Roberto Andrade Lima · 2016 · Molecular and integrative toxicology
16. Genotoxic effects of complex influence of radon and heavy metals depending on polymorphism of genes of enzymes monoxygenase systems
    Varvara Ivanovna Minina, Vladimir Gennadyevich Druzhinin, Andrey N. Glushkov, Tatyana A Golovina, Светлана Вячеславовна Апалько, Alexey N. Volkov, Ахматьянова Венера Ринатовна, Anna A Lunina, Ларионов Алексей Викторович · 2009 · Ecological genetics
17. Genome-wide Association Study of Caffeine Consumption Using Coriell Personalized Medicine Collaborative Data
    Dara Kusic, Stefan C. Zajic, Neda Gharani, Erynn S. Gordon, Tara Schmidlen, Pan Zhang, Norman P. Gerry, Laura Scheinfeldt · 2023 · Genetics & Molecular Medicine
18. Cytochrome P450 Polymorphisms
    Ulrich M. Zanger · 2012 · Encyclopedia of Drug Metabolism and Interactions
19. Coffee and Risk of Type 2 Diabetes
    Siamak Bidel, J. Tuomilehto · 2007 · Työväentutkimus Vuosikirja
20. Maternal Caffeine Consumption and its Relationship to Adverse Pregnancy Outcomes
    Neelam Potdar · 2010 · Figshare
21. Genetic Modifiers of Caffeine Consumption and Risk of Myocardial Infarction
    Laura Anne Da Costa · 2011 · TSpace (University of Toronto)
22. Variability of caffeine metabolism by CYP1A2 polymorphism in different populations
    Pieranna Chiarella, Pasquale Capone, Renata Sisto · 2023 · Research Square
23. Caffeine intake and the plasma proteome
    Ouxi Tian, Andrea R. Josse, Ahmed El‐Sohemy · 2013 · The FASEB Journal
24. CYP1A2 (Sitokrom P450 1A2) Genotiplerine (AA, AC, CC) Göre Kafein Metabolizma Hızlarının Atletik Performansa Etkileri
    Sibel Tetik Dündar · 2022 · Akdeniz Spor Bilimleri Dergisi
25. Genetic polymorphisms predisposing to common cardiovascular diseases
    Olga Antonova, Sofia Todorova · 2023 · Annual for Hospital Pharmacy
26. A Comprehensive Review of Schizophrenia and Antipsychotic Metabolism as a Predictor of Treatment Response
    M. Pham, Aydin Caglayan · 2024 · Cureus
27. Association between daily coffee intake and diabetic kidney disease: evidence from the 2007 to 2016 NHANES
    Ke Xiong, Tianshu Gao · 2025 · International Urology and Nephrology
28. Pharmacogenetic Considerations in Caffeine Toxicity: Insights Prompted by the “Death Coffee” Case Series
    Yuji Kamikubo · 2025 · Neuropsychopharmacology Reports
29. Pathogen-specific drug metabolism in tuberculosis: Enzymes, metabolic pathways, and new horizons in therapeutic development
    Periyasamy Vijayalakshmi, Faiz Abdulaziz Alfaiz, Rajendran Vijayakumar, Deepali Desai, Chandrabose Selvaraj · 2025 · Microbial Pathogenesis
30. PharmVar GeneFocus: CYP1A2 —Clinical Impact, Genetic Variation, and Updated Nomenclature
    Katalin Monostory, Gonzalo Villapalos‐García, Dóra Koller, Solomon M. Adams, Chad Bousman, Evangelia Eirini Tsermpini, Michelle Whirl‐Carrillo, Amy Turner, Volker Martin Lauschke, Mohamed Nagy et al. · 2026 · Clinical Pharmacology & Therapeutics
31. Stimulant Reversal of Cognitive Deficits
    Nancy Jo Wesensten · 2012 · Cambridge University Press eBooks
32. Frequency of Two Genetic Polymorphisms of CYP1A2 Gene in Iranian Population
    M. Samimifar · 2014 · Annual Research & Review in Biology
33. Gene (CYP1A2, CYP2F1, NQO1, UGT2B7, CAT, GSTP1) - environment interactions analysis in occupational chronic bronchitis
    Leysan Zinurovna Akhmadishina, Gulnaz Faritovna Korytina, О. В. Кочетова, Tatiana V. Viktorova · 2014 · Ecological genetics
34. Pharmacogenomics in Thrombosis
    Shaker A. Mousa · 2010 · Methods in molecular biology
35. Effects of Coffee and Caffeine on Mood and Mood Disorders
    Ahmed Radwan, Rand T. Akasheh, Sara Talaat, Luai Shaaban, Krishna Taneja, C L Parks · 2024 · Nutritional neurosciences
36. Effect of different doses of caffeine on speed and strength parameters of freestyle wrestlers: a pilot study
    Polina Denisovna Rybakova, A. G. Antonov, Alexander B. Miroshnikov · 2024 · Medical alphabet
37. Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia
    Toshihiro Sato, Takeshi Kawabata, Masaki Kumondai, Nagomi Hayashi, Hiroshi Komatsu, Yuki Kikuchi, Go Onoguchi, Yu Sato, Kei Nanatani, Masahiro Hiratsuka et al. · 2024 · International Journal of Molecular Sciences
38. Clinical Pharmacogenetics of Olanzapine : with Focus on FMO Gene Polymorphisms
    Mao Mao Söderberg · 2012
39. Interactions of tizanidine with CYP1A2 enzyme inhibitors : Studies in vitro and in humans
    Marika T. Granfors · 2005
40. Coffee and Hypertension
    Giulia Renda, Raffaele De Caterina · 2014 · Coffee in Health and Disease Prevention
41. Molecular genetic analysis of genes for detoxification and DNA repair in children with congenital deformities of the thoracic and lumbar spine
    Marina Vanikovna Sogoyan, Хальчицкий Сергей Егорович, Sergei Valentinovich Vissarionov, Dmitriy Nikolaevich Kokushin, A.N. Filippova · 2018 · Pediatric Traumatology Orthopaedics and Reconstructive Surgery
42. Preliminary Studies on Genetic Profiling of Coffee and Caffeine Consumption
    Roseane Maria Maia Santos · 2019 · Beverages
43. ASSOCIATION BETWEEN SMOKING AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL
    K. Yu. Lukianets, Лындина Мария Леонидовна · 2020 · Juvenis scientia
44. Study on herb-drug interactions
    Liu L. Yang · 2011 · RMIT Research Repository (RMIT University Library)
45. The influence of the CYP1A2 polymorphism on the effect of caffeine ingestion and mouth rinsing on 3km cycling performance
    Mark William Pataky · 2015 · JMU Scholoraly Commons (James Madison University)
46. Pharmacogenetic screening of docetaxel, irinotecan and fluoropyrimidines in cancer therapy
    Tessa M. Bosch · 2006 · Utrecht University Repository (Utrecht University)
47. Pharmacogenetics in Drug Metabolism: Role of Phase I Enzymes
    Vita Dolžan · 2012 · Wiley eBooks
48. Drug-induced movement disorders in long-stay psychiatric patients : genetic and non-genetic risk factors : a prospective study
    Pieter Roberto Bakker · 2012
49. Human genetic variation with implications for healthcare in Ethiopian populations
    Sarah L. Browning · 2010 · UCL Discovery (University College London)
50. Genetic, epigenetic and environmental factors of importance for CYP1A2 catalyzed drug metabolism
    Roza Ghotbi · 2008 · Figshare
51. Cytochrome P450: Another Player in the Myocardial Infarction Game?
    Raute Sunder‐Plaßmann · 2006 · Advances in clinical chemistry
52. Flavonoid induction of cytochrome P450 (CYP) in human esophageal carcinoma cells: implications for chemotherapy
    Ramaesela Sharon Molepo · 2011 · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
53. The effect of the CYP1A2 -163 C>A polymorphism on the metabolism of caffeine and effect on performance
    Gabrielle E. W. Giersch · 2016 · JMU Scholoraly Commons (James Madison University)
54. The efficacy of caffeine supplementation in collegiate tennis players and the magnitude of improvement in tennis skill mediated by caffeine influenced by a polymorphism of the CYP1A2 gene
    Courtney S. Klein · 2010 · JMU Scholoraly Commons (James Madison University)
55. Clozapin und Rauchstopp: Der Tabakrauch, nicht Nikotin induziert CYP1A2
    PL Stephan, I Baltensperger, M. Etzensberger, Eveline Jaquenoud Sirot · 2006 · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
56. VARIABILITE INTERINDIVIDUELLE PHARMACOCINETIQUE ET PHARMACODYNAMIQUE EN ONCOLOGIE : APPLICATION AU DOCETAXEL ET A LA VINORELBINE
    Florent Puisset · 2007
57. Analysis of the CYP1A2 caffeine metabolism gene in the student population at Lake Superior State University
    Rebekka A Pittsley, Stephen H. Kolomyjec · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
58. Pharmacokinetic interactions of clozapine in hospitalized patients
    Kari Raaska · 2003 · Työväentutkimus Vuosikirja
59. Pharmacological Treatment of Depression in Hispanic Americans
    Alex J. Kopelowicz, Humberto Marín, Michael W. Smith · 2008 · Issues in children's and families' lives
60. Melatonin for sleep problems in individuals with intellectual disabilities: a study into its effectiveness and clinical aspects
    Wiebe Braam · 2010
61. Molecular methods for genotyping selected detoxification and DNA repair enzymes
    Jeanine Labuschagne · 2010 · Boloka Institutional Repository (North-west University)
62. Drug-Metabolizing Enzymes and P-Glycoprotein
    Thomas K. H. Chang · 2004 · Humana Press eBooks
63. Genetic susceptibility for environmental carcinogenesis : a biomarker approach
    Hans B. Ketelslegers · 2007
64. Pharmacogenetics and Pharmacogenomics
    Lilian G. Yengi · 2010 · Pharmaceutical Sciences Encyclopedia
65. Suszeptibilitätsmarker [Biomonitoring Methods in German language, 2004]
    Ricarda Thier, Beate Pesch, G. Krause, Thomas Schulz · 2012 · The MAK-Collection for Occupational Health and Safety
66. New Insights into Genetic Variation and Cancer
    Claire Siemes · 2007 · EUR Research Repository (Erasmus University Rotterdam)
67. Contribution of drug metabolizing enzymes in gene-gene and gene-environment interactions in lung carcinogenesis
    Sutira Lerdtragool · 2002 · D-Scholarship@Pitt (University of Pittsburgh)
68. Phase I enzyme genotypes and their toxicologically relevant phenotypes.
    Roger Godschalk, Frederik‐Jan van Schooten · 2008
69. Genetic diversity and expression variation in human cytochrome P450 genes.
    Zhengwen Jian · 2008 · OhioLink ETD Center (Ohio Library and Information Network)
70. In Case of Treatment-Resistant Schizophrenia, Pharmacogenetic Tests Could Be Helpful to Explain the Resistance and the Selection of New Drugs
    Esra SAĞLAM, Nevzat Tarhan, Emine Nur Özdamar, İ. Yaman SAĞLAM · 2015 · Turkiye Klinikleri Journal of Case Reports
71. What advice should be given to pregnant mothers on caffeine consumption?
    Bodil Hammer Bech · 2011 · Expert Review of Obstetrics & Gynecology
72. Genotoxic effects of the combined influence of radon and heavy metals depending on polymorphism of genes of monooxygenase system enzymes
    Varvara Ivanovna Minina, Vladimir Gennadyevich Druzhinin, Andrey N. Glushkov, T. A. Golovina, Светлана Вячеславовна Апалько, Alexey N. Volkov, Ахматьянова Венера Ринатовна, Anna A Lunina, Ларионов Алексей Викторович · 2011 · Russian Journal of Genetics Applied Research
73. Coffee, Myocardial Infarction, and CYP Nomenclature—Reply
    Marilyn C. Cornelis, Ahmed El‐Sohemy, Edmond Kato Kabagambe, Hannia Campos · 2006 · JAMA
74. BJCP 40th anniversary: moving forward, looking back
    Annette Gilchrist, Yoon Kong Loke, Andrew Alexander Somogyi, Adam F. Cohen, James M. Ritter · 2014 · British Journal of Clinical Pharmacology
75. Genetic association analysis of polymorphisms in four cytochrome P450 genes, the MDR1 gene and treatment-outcome in Xhosa schizophrenia patients
    Erika Truter · 2007 · SUNScholar (Stellenbosch University)
76. Methadone population pharmacokinetics: toward understanding the dose-response relationship in the treatment of opiate addiction
    Gavin B. Bart · 2013 · University of Minnesota Digital Conservancy (University of Minnesota)
77. Pharmacogenetics of oral anticoagulant therapy.
    Teodora Pop, D. N. Chirilă, Anca Dana Buzoianu · 2013
78. A Comparison of the Effect of Omeprazole and Rabeprazole on Clozapine Serum Concentrations
    Naghmeh Jabarizadekivi · 2007 · The Sydney eScholarship Repository (The University of Sydney)
79. Métabolisme et mécanisme d’action de la caféine
    Évelyne Kaupt · 2014 · Pratiques en nutrition
80. Stabile Expression von Sulfotransferasen - allein oder in Kombination mit Cytochrom P450 - in Zelllinien für Mutagenitätsuntersuchungen
    Mathematisch-naturwissenschaftlichen Fakultät I · 2003
81. A hipótese do citocromo P450 na etiologia do suicídio
    Sandra Patrícia Santos Mondego · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
82. Genetic Determinants of the Acute Effects and Withdrawal Symptoms of Caffeine
    Erica Lynne Day Tasevski · 2010 · TSpace (University of Toronto)
83. Pharmacogenomics and Coagulation Disorders
    Omer Iqbal · 2004 · Humana Press eBooks
84. TOOLS IN PHARMACOVIGILANCE IN PSYCHIATRY: THERAPEUTIC DRUG MONITORING, PHARMACOGENETIC TESTS AND DRUG-DRUG INTERACTIONS DATABASES
    Jaquenoud Sirot Eveline · 2011
85. Nutrigenomics and Pharmacogenomics of Human Cancer
    Alexandre S. Loktionov · 2006 · Nutrition and disease prevention
86. The Genetics of Antipsychotic Response: Pharmacogenetic and Pharmacogenomic Investigations and Clinical Applications
    Maria Jesús Arranz, Dalu T. Mancama, Robert W Kerwin · 2016
87. Investigation tools for metabolic enzymes in clinical practice
    Caroline Flora Samer, Victoria Rollason, Kuntheavy Ing Lorenzini, Youssef Daali · 2013
88. The influence of time-of-day consumption and training status on the ergogenic properties of caffeine
    James C. Boyett · 2016 · JMU Scholoraly Commons (James Madison University)
89. Measuring Fluorescence Anisotropy as One of Very Useful Analytical Methods to Obtain Detailed Information of the Complex Binding Interaction
    Seongkyung Lee, Sungho Huh · 2017 · Bulletin of the Korean Chemical Society
90. Genetic Variability in Caffeine Acute Effects and Withdrawal Symptoms
    Joanne Margaret Brathwaite · 2011 · TSpace (University of Toronto)
91. Arzneimittelspiegel als pharmakotherapeutisches Werkzeug bei der Behandlung mit Psychopharmaka Therapeutic Drug Monitoring: A Pharmacotherapeutic Tool in Psychiatry
    M. Etzensberger, Eveline Jaquenoud Sirot · 2006
92. Acute Impaired Glucoregulation and Disrupted Gastrointestinal Hormone Secretion in Adolescents in Response to Caffeine-Containing and Nutritionally Fortified “Energy Shots”
    Heidi Virtanen · 2017 · Libraries and Cultural Resources (University of Calgary)
93. Genetic polymorphisms in AH receptor and cytochrome P450 drug-metabolizing enzymes in relation to estradiol metabolism and breast cancer susceptibility
    Maria S. M. Lam · 2000 · Library and Archives Canada (Government of Canada)
94. Estudo epidemiológico do consumo de café, sua contribuição na ingestão de polifenóis e seus potenciais efeitos em fatores de risco cardiovascular, considerando variações genéticas individuais
    Andreia Alexandra Machado Miranda · 2018
95. Biotransformation of the Analgesic-Antipyretic Drugs Metamizole and Aminopyrine by Genetically Polymorphic Enzymes
    Salem O.A. Abdalla · 2007 · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG))
96. Genomics and Drug-Metabolizing Enzymes and Its Application in Drug Delivery: Evaluating the Influence of the Microbiome
    Sheeba Varghese Gupta · 2018 · Springer eBooks
97. Aminophylline: Developing Evidence Based Dosage and Monitoring Strategies for Children
    Lewis Cooney · 2016 · University of Liverpool
98. Sleep and the impact of caffeine, supplements, and other stimulants
    Ninad S. Chaudhary, Priyamvada M. Pitale, Favel L. Mondesir · 2019 · Elsevier eBooks
99. A gyógyszer-metabolizáló képességhez igazított pszichofarmakoterápia lehetőségei
    Tóth, Katalin · 2017 · Eötvös Loránd Tudományegyetem
100. Development of two different pharmacogenomics detection methods for second-generation antipsychotic drugs quetiapine and aripiprazole
     Lichen Zhang, Xingyu Zhang, Xiaoqing Zhang, Guoling You, Qihua Fu · 2020 · Journal of Bio-X Research